Commitments And Contingencies

12 Months Ended

Jun. 30, 2013

Commitments And Contingencies [Abstract]

Commitments And Contingencies

13.Commitments and Contingencies

Leases

The Company leases its facility and certain equipment under non-cancelable operating leases that expire at various dates through fiscal year 2016.  Rent expense related to operating leases was approximately $227,000, $216,000, and $197,000 for the years ended June 30, 2013, 2012 and 2011, respectively.  On September 9, 2010, the Company entered into a new lease agreement with our current landlord, covering the same square footage, for a period of seventy-two months, effective August 1, 2010. Future minimum annual lease commitments under non-cancelable operating leases with initial terms of one year or more are as follows: 

	2014		2015		2016		2017		2018
Building and equipment leases	$	224	$	225	$	228	$	31	$	5

Prostiva Payments

Prostiva payments are commitments related to the acquisition of the Prostiva RF Therapy product line from Medtronic on September 6, 2011 (see Note 4 for more details).  In addition, on June 28, 2013, we entered into a promissory note (the “Note”) with Medtronic for $5.3 million for the remaining amounts owed on Prostiva inventory acquired as part of the acquisition and purchased subsequent to the acquisition (see Footnote 12 for more details).

		Fiscal Years
	2014		2015		2016		2017		2018
Prostiva Payments
Annual license maintenance fee	$	65		65		65		65		65
Note payments, including interest		-		1,342		1,342		1,342		1,342
	$	65	$	1,407	$	1,407	$	1,407	$	1,407

Contingencies

We have been and are involved in various legal proceedings and other matters that arise in the normal course of our business, including product liability claims that are inherent in the testing, production, marketing and sale of medical devices.  The ultimate liabilities, if any, cannot be determined at this time. However, based upon currently available information, we believe that the ultimate resolution of these matters will not have a material effect on the financial position, liquidity or results of operations of the Company.